nedaplatin has been researched along with Ovarian Neoplasms in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (9.68) | 18.7374 |
| 1990's | 8 (25.81) | 18.2507 |
| 2000's | 6 (19.35) | 29.6817 |
| 2010's | 11 (35.48) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Wu, J; Zhu, G | 1 |
| Chikazawa, K; Imai, K; Ishiguro, A; Kimura, A; Konno, R; Kuwata, T; Netsu, S; Wang, L | 1 |
| Endo, Y; Fujimori, K; Furukawa, S; Kamo, N; Manabu, K; Nishigori, H; Nomura, S; Okabe, C; Sato, T; Soeda, S; Takahashi, T; Ueda, M; Watanabe, T | 1 |
| Fujiwara, K; Ogasawara, A; Shintani, D; Yoshida, H | 1 |
| Chen, J; Ding, Y; Ma, L; Zhang, L; Zhuang, Y | 1 |
| Jiang, H; Sheng, WJ; Wu, DL; Zheng, JH | 1 |
| Hu, T; Liu, H; Shi, Y; Song, SQ; Zhang, GN | 1 |
| Asami, Y; Iiba, M; Kitagawa, R; Kondo, K; Sato, N; Sugita, M; Tadauchi, K; Tsunoda, H; Uenoyama, A | 1 |
| Gao, H; Han, Y; Yuan, L | 1 |
| Fujiwara, K; Goto, T; Hasegawa, K; Iwasa, N; Nagao, S; Ohishi, R; Shimizu, M; Takano, M | 1 |
| Fujiwara, H; Itamochi, H; Kigawa, J; Machida, S; Oishi, T; Sato, S; Shimada, M; Suzuki, M; Takei, Y | 1 |
| Ota, T; Takeshima, N; Takizawa, K | 1 |
| Dai, HY; Huang, XE; Li, SY; Shi, FF; Su, XY; Tan, HY; Yin, HT | 1 |
| Duan, Z; Hu, P; Yue, Y; Zhou, X | 1 |
| Maekawa, R; Uchida, N; Yamada, H; Yoshioka, T | 1 |
| Kamiura, S; Morishige, K; Ohta, Y; Saji, F; Yamamoto, T | 1 |
| Ichikawa, Y; Nishida, M; Tsunoda, H; Yoshikawa, H | 1 |
| Feng, FY; Gao, YJ; Guan, XQ; Hu, Y; Li, CW; Liu, JW; Nan, KJ; Suo, AL; Wang, XW; Wu, LY; Zhang, MH; Zhang, P; Zhang, WD; Zhang, Y; Zhao, JB | 1 |
| Jobo, T | 1 |
| Eastman, A; Hom, DK; Howell, SB; Isonishi, S | 1 |
| Ota, K | 1 |
| Adair, LP; Alberts, DS; Fanta, PT; Garcia, DJ; Liu-Stevens, R; Running, KL; Salmon, SE | 1 |
| Fujii, H; Igarashi, T; Itoh, K; Kodama, K; Minami, H; Ohtsu, T; Sasaki, Y; Wakita, H; Watanabe, Y; Yamashita, T | 1 |
| Adachi, S; Beppu, K; Chin, R; Hori, K; Itani, Y; Ito, K; Kawai, S; Koyama, M; Saito, K; Shintani, M | 1 |
| Daikatsu, K; Ikeuchi, I; Maekawa, R; Sugita, K; Uchida, N; Wada, T; Yamada, H; Yoshida, H; Yoshioka, T | 1 |
| Kubo, T; Nishida, M; Nishide, K; Satoh, Y; Tsunoda, H | 1 |
| Hongo, A; Kawanishi, K; Kodama, J; Kudo, T; Miyagi, Y; Nakamura, K; Yamamoto, J; Yoshinouchi, M | 1 |
| Arai, M; Kato, T; Nishimura, H; Noda, K; Ota, M; Suzuki, M; Takamizawa, H; Takeuchi, S; Terashima, Y; Yakushiji, M | 1 |
| Suzumori, K; Yagami, Y; Yasui, Y | 1 |
| Nishimura, H; Yakushiji, M | 1 |
| Hamaguchi, K; Kato, T; Kishi, N; Matsumura, T; Miyahara, K; Nishimura, H; Tashiro, M; Yakushiji, M | 1 |
1 review(s) available for nedaplatin and Ovarian Neoplasms
| Article | Year |
|---|---|
[Cisplatinum compounds].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Testicular Neoplasms | 1993 |
8 trial(s) available for nedaplatin and Ovarian Neoplasms
| Article | Year |
|---|---|
Evaluation of a formula for individual dosage of nedaplatin based on renal function.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Blood Platelets; Female; Humans; Kidney; Kidney Function Tests; Metabolic Clearance Rate; Middle Aged; Models, Theoretical; Organoplatinum Compounds; Ovarian Neoplasms; Platelet Count; Precision Medicine; Predictive Value of Tests; Uterine Cervical Neoplasms | 2012 |
[Combination chemotherapy with nedaplatin and paclitaxel for ovarian cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Thrombocytopenia; Treatment Outcome | 2004 |
[Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Organoplatinum Compounds; Ovarian Neoplasms; Vinblastine; Vinorelbine | 2006 |
[Cisplatinum compounds].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Testicular Neoplasms | 1993 |
A dose-finding study of nedaplatin and cyclophosphamide for patients with gynecological malignancies.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Erythrocyte Count; Feasibility Studies; Female; Humans; Infusions, Intravenous; Leukocyte Count; Middle Aged; Neutrophils; Organoplatinum Compounds; Ovarian Neoplasms; Platelet Count; Remission Induction; Survival Rate; Uterine Cervical Neoplasms | 1999 |
[Phase I study of a combination chemotherapy of nedaplatin and cisplatin].
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1999 |
[Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting | 1992 |
[Current status of CDDP analogs in gynecologic malignancies].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Doxorubicin; Drug Evaluation; Female; Genital Neoplasms, Female; Humans; Japan; Middle Aged; Multicenter Studies as Topic; Organoplatinum Compounds; Ovarian Neoplasms; Remission Induction; Uterine Cervical Neoplasms | 1989 |
23 other study(ies) available for nedaplatin and Ovarian Neoplasms
| Article | Year |
|---|---|
Efficacy Analysis of Comprehensive Nursing in the Care of Ovarian Carcinoma Treated with Paclitaxel Combined with Nedaplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Nerve Growth Factor; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel | 2022 |
Nedaplatin use in patients with hypersensitivity reaction episodes to carboplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Case-Control Studies; Drug Hypersensitivity; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Retrospective Studies | 2020 |
Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Combined Modality Therapy; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Phthalazines; Piperazines; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Feasibility and response to nedaplatin monotherapy in older patients with ovarian cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Feasibility Studies; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Retrospective Studies; Treatment Outcome | 2017 |
A rare case report of ovarian juvenile granulosa cell tumor with massive ascites as the first sign, and review of literature: Case report and review of literature.
Topics: Abdominal Cavity; Antineoplastic Agents; Ascites; CA-125 Antigen; Chemotherapy, Adjuvant; Female; Granulosa Cell Tumor; Humans; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Salpingo-oophorectomy; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Young Adult | 2018 |
Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; bcl-X Protein; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Migration Assays; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Oxazines; Rats; Signal Transduction; STAT3 Transcription Factor; Survivin; Vascular Endothelial Growth Factor A; Xanthenes | 2013 |
Addition of bevacizumab to neoadjuvant chemotherapy for Stage IV ovarian serous adenocarcinoma with multiple lymph node metastases: a case report.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemoradiotherapy, Adjuvant; Female; Humans; Lymph Nodes; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Organoplatinum Compounds; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Treatment Outcome | 2015 |
[A Patient with Recurrent Ovarian Cancer Who Was Hypersensitive to Carboplatin Exhibited Complete Response to Gemcitabine and Nedaplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Drug Hypersensitivity; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Recurrence | 2015 |
Comparisons of the survival time of patients with ovarian cancer adopting post-operative chemotherapy by use of paclitaxel combined with carboplatin or nedaplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Postoperative Care; Prognosis; Survival Rate | 2016 |
Single nedaplatin treatment as salvage chemotherapy for platinum/taxane-resistant/refractory epithelial ovarian, tubal and peritoneal cancers.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Disease-Free Survival; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Salvage Therapy; Treatment Outcome | 2010 |
Second-line chemotherapy for carboplatin/paclitaxel-refractory ovarian cancer: are multi-agent chemotherapies of little value truly?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids | 2011 |
Intervention effects of nedaplatin and cisplatin on proliferation and apoptosis of human tumour cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma; Cell Proliferation; Cisplatin; Drug Synergism; Esophageal Neoplasms; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Ki-67 Antigen; Organoplatinum Compounds; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger | 2012 |
A case of occult bowel perforation after a cycle of chemotherapy for advanced epithelial ovarian carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Female; Humans; Intestinal Perforation; Neoadjuvant Therapy; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel | 2012 |
[Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel | 2002 |
Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinoma.
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Parity; Treatment Outcome | 2004 |
[Outpatient chemotherapy in gynecologic oncology].
Topics: Ambulatory Care Facilities; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Irinotecan; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms | 2006 |
Enhancement of sensitivity to platinum(II)-containing drugs by 12-O-tetradecanoyl-phorbol-13-acetate in a human ovarian carcinoma cell line.
Topics: Carboplatin; Cisplatin; Cystadenocarcinoma, Serous; DNA, Neoplasm; Drug Synergism; Enzyme Activation; Female; Glutathione; Glutathione Transferase; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Protein Kinase C; Pyrazoles; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1994 |
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Drug Screening Assays, Antitumor; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms | 1997 |
Successful treatment with nedaplatin in patients with ovarian cancer that recurred after platinum-containing chemotherapy: report of two cases.
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Ovarian Neoplasms | 1998 |
Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Body Weight; Cell Division; Cisplatin; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms; Survival Rate; Tumor Cells, Cultured | 1999 |
Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters.
Topics: Antineoplastic Agents; Area Under Curve; Cell Survival; Colony-Forming Units Assay; Cross-Linking Reagents; Culture Media; DNA Damage; DNA, Neoplasm; Female; Half-Life; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Tumor Cells, Cultured | 2001 |
[Comparative studies of the antitumor activities of CDDP and the analogs--using gynecological carcinomas transplanted into nude mice].
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms; Prognosis; Transplantation, Heterologous; Uterine Neoplasms | 1989 |
Antitumor activity of cisplatin analogs against malignant ovarian tumor xenografts into nude mice.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line; Cisplatin; Cystadenocarcinoma; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms | 1988 |